Stock CYTO CYTOPHAGE TECHNOLOGIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Cytophage Technologies Ltd.

Equities

CYTO

CA2328211081

Market Closed - Toronto S.E.
Other stock markets
 01:29:05 22/06/2024 am IST 		5-day change 1st Jan Change
0.39 CAD 0.00% Intraday chart for Cytophage Technologies Ltd. -11.36% -44.65%
27/05 Cytophage Technologies Ltd. Strengthens Board of Directors CI
30/04 Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Cytophage Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Cytophage Technologies Ltd. Appoints Michael D. Cochrane as Newest Member of Board of Directors
CI
Cytophage Technologies Ltd. Provides Update on Bacteriophage Human Trial at The Ottawa Hospital
CI
Cytophage Technologies Ltd. Provides Update on Upcoming Product for Egg Production in Canada
CI
Cytophage Technologies Inc. completed the acquisition of Cuspis Capital III Ltd. (TSXV:CIII.P) in a reverse merger transaction.
CI
Cuspis Capital III Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Cuspis Capital III Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Cytophage Technologies Inc. entered into a letter of intent to acquire Cuspis Capital III Ltd. (TSXV:CIII.P) in a reverse merger transaction.
CI
Cuspis Capital III Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Cuspis Capital III Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Cuspis Capital III Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Cuspis Capital III Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Cuspis Capital III Ltd. has completed an IPO in the amount of CAD 5 million.
CI
Cuspis Capital III Ltd. has filed an IPO in the amount of CAD 5 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. News Cytophage Technologies Ltd.
  5. Highlights